Last reviewed · How we verify
long acting oxycodone
At a glance
| Generic name | long acting oxycodone |
|---|---|
| Sponsor | University of Chicago |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ultrasound-guided Block of the Supraclavicular Nerves in Clavicular Fractures (NA)
- Comparison of the Infraclavicular and Axillary Approaches for Continuous Ultrasound-guided Brachial Plexus Block. (NA)
- Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer (EARLY_PHASE1)
- Non-cancer Pain and Cognitive Impairment: A Disabling Relationship (PHASE4)
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer (NA)
- CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial (PHASE4)
- Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- long acting oxycodone CI brief — competitive landscape report
- long acting oxycodone updates RSS · CI watch RSS
- University of Chicago portfolio CI